what is a glp-1/gip Simplified summary of the biological actions of GIP and GLP-1 as GLP-1 V2 - Regenics

Description

Retrieved from GLP-1 Agonists

Olykor, ezek tartalmazhatnak tves informcikat: a kpek tjkoztat jellegek s tartalmazhatnak tartozkokat, amelyek nem szerepelnek az alapcsomagban, egyes lersok vagy az rak elzetes rtests nlkl megvltozhatnak a gyrtk ltal, vagy hibkat tartalmazhatnak

In total, the review analysed 48 placebo-controlled randomised controlled trials (RCTs) involving 94,245 participants that evaluated the efficacy or safety of GLP-1RAs/dual agonists in adult patients with T2DM or overweight or obesity that reported on any of the following cancer outcomes: thyroid, pancreatic, colorectal, gastric, oesophageal, liver, gallbladder, breast, ovarian, endometrial, kidney cancer multiple myeloma and meningioma

Another recently published review (Wu et al., BMC Medicine, 2025 ) looked at a range of studies on this subject to provide an overview of what happens when these medications are stopped

Glucagon-like peptide-1 (GLP-1) receptor agonists were originally developed to treat people with type 2 diabetes, entering clinical use in the mid-2000s